HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efstathios Kastritis Selected Research

Osteocalcin

1/2014The combination of lenalidomide and dexamethasone reduces bone resorption in responding patients with relapsed/refractory multiple myeloma but has no effect on bone formation: final results on 205 patients of the Greek myeloma study group.
11/2012Increased angiogenesis and enhanced bone formation in patients with IgM monoclonal gammopathy and urticarial skin rash: new insight into the biology of Schnitzler syndrome.
1/2007Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Efstathios Kastritis Research Topics

Disease

117Multiple Myeloma
03/2024 - 11/2004
49Immunoglobulin Light-chain Amyloidosis
12/2023 - 10/2007
45Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2024 - 06/2007
43Neoplasms (Cancer)
01/2024 - 01/2005
27Amyloidosis
10/2023 - 01/2008
19Paraproteinemias (Monoclonal Gammopathy)
02/2024 - 12/2008
19COVID-19
09/2023 - 01/2020
13Bone Diseases (Bone Disease)
02/2024 - 03/2009
10Monoclonal Gammopathy of Undetermined Significance
02/2024 - 06/2007
9Disease Progression
02/2024 - 03/2016
8Bone Resorption
11/2018 - 05/2006
6Infections
09/2023 - 10/2019
6Chromosome Aberrations (Chromosome Abnormalities)
09/2023 - 07/2012
6Residual Neoplasm
12/2021 - 10/2019
6Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2018 - 01/2009
5B-Cell Lymphoma (Lymphoma, B Cell)
01/2024 - 06/2018
5Peripheral Nervous System Diseases (PNS Diseases)
01/2023 - 04/2013
5Inflammation (Inflammations)
08/2022 - 02/2011
5Amyloid Plaque
08/2020 - 03/2015
5Renal Insufficiency (Renal Failure)
05/2016 - 04/2007
4Thrombosis (Thrombus)
02/2024 - 07/2016
4Pain (Aches)
09/2023 - 12/2008
4Thrombotic Microangiopathies
01/2023 - 01/2016
4Lymphoma (Lymphomas)
01/2023 - 12/2019
4Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 03/2007
4Ovarian Neoplasms (Ovarian Cancer)
10/2021 - 01/2006
4Osteonecrosis (Kienbock's Disease)
10/2017 - 12/2005
4Cytopenia
01/2016 - 01/2009
4Carcinoma (Carcinomatosis)
01/2009 - 01/2006
3Cardiomyopathies (Cardiomyopathy)
10/2023 - 01/2021
3Cardiotoxicity
01/2023 - 01/2019
3Heart Failure
11/2022 - 01/2021
3Proteinuria
08/2022 - 04/2014
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2022 - 03/2007
3Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2022 - 09/2021
3Plasmacytoma
01/2020 - 01/2018
3Hypercalcemia (Milk Alkali Syndrome)
01/2020 - 11/2017
3POEMS Syndrome (Syndrome, POEMS)
01/2020 - 07/2006

Drug/Important Bio-Agent (IBA)

44Bortezomib (Velcade)FDA Link
10/2023 - 04/2007
42Dexamethasone (Maxidex)FDA LinkGeneric
02/2024 - 04/2007
31Lenalidomide (CC 5013)FDA Link
03/2024 - 03/2007
23Immunoglobulin M (IgM)IBA
02/2024 - 06/2007
18daratumumabIBA
01/2024 - 01/2018
17Biomarkers (Surrogate Marker)IBA
01/2024 - 07/2006
17Amyloid (Amyloid Fibrils)IBA
12/2023 - 02/2010
17Proteins (Proteins, Gene)FDA Link
03/2023 - 01/2007
16Proteasome InhibitorsIBA
08/2023 - 10/2007
14Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2023 - 04/2007
14carfilzomibIBA
01/2023 - 01/2016
13Rituximab (Mabthera)FDA Link
10/2023 - 09/2008
13Monoclonal AntibodiesIBA
09/2023 - 03/2009
12VaccinesIBA
09/2023 - 01/2021
11BNT162 VaccineIBA
11/2022 - 01/2021
10Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
10/2023 - 02/2010
10Neutralizing AntibodiesIBA
09/2023 - 01/2021
10Thalidomide (Thalomid)FDA Link
01/2022 - 11/2004
10Immunoglobulins (Immunoglobulin)IBA
10/2021 - 12/2008
8CreatinineIBA
02/2024 - 05/2008
8Diphosphonates (Bisphosphonates)IBA
01/2020 - 12/2005
7belantamab mafodotinIBA
02/2024 - 01/2021
7Prealbumin (Transthyretin)IBA
10/2023 - 01/2019
7Zoledronic Acid (Zometa)FDA Link
10/2017 - 12/2005
6AntibodiesIBA
09/2023 - 06/2016
6Melphalan (Alkeran)FDA LinkGeneric
03/2022 - 10/2007
6PlatinumIBA
01/2020 - 01/2006
6L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2020 - 03/2009
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2012 - 01/2005
5Immunomodulating AgentsIBA
01/2024 - 01/2013
5ibrutinibIBA
02/2023 - 06/2018
5DNA (Deoxyribonucleic Acid)IBA
01/2023 - 12/2018
5Angiopoietin-2IBA
10/2017 - 06/2007
5Angiopoietin-1IBA
10/2017 - 06/2007
5CytokinesIBA
11/2012 - 06/2007
4ixazomibIBA
01/2023 - 05/2020
4MicroRNAs (MicroRNA)IBA
01/2023 - 07/2021
4Cell-Free Nucleic AcidsIBA
11/2022 - 12/2018
4Proteasome Endopeptidase Complex (Proteasome)IBA
11/2022 - 04/2013
4mRNA VaccinesIBA
10/2022 - 01/2021
4Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 06/2005
4Cisplatin (Platino)FDA LinkGeneric
01/2020 - 01/2006
4Cystatin CIBA
01/2019 - 03/2009
4Pamidronate (Aredia)FDA LinkGeneric
10/2015 - 12/2005
4OsteoprotegerinIBA
01/2014 - 05/2006
4Alkaline PhosphataseIBA
01/2014 - 01/2007
4collagen type I trimeric cross-linked peptideIBA
01/2014 - 07/2006
4angiogeninIBA
11/2012 - 06/2007
3RNA (Ribonucleic Acid)IBA
02/2024 - 01/2021
3AlbuminsIBA
02/2024 - 06/2007
3ParaproteinsIBA
01/2024 - 11/2017
3Messenger RNA (mRNA)IBA
09/2023 - 01/2021
3pro-brain natriuretic peptide (1-76)IBA
09/2022 - 04/2013
3Nerve Growth Factor (NGF)IBA
12/2021 - 12/2019
3ChAdOx1 nCoV-19IBA
11/2021 - 01/2021
3pomalidomideIBA
12/2019 - 01/2013

Therapy/Procedure

82Therapeutics
03/2024 - 06/2005
21Drug Therapy (Chemotherapy)
02/2024 - 01/2005
7Stem Cell Transplantation
09/2023 - 10/2007
4Aftercare (After-Treatment)
01/2023 - 12/2005
4Autologous Transplantation
08/2021 - 01/2009
3Salvage Therapy
12/2018 - 01/2009